Mustang Bio, Inc. (MBIO)
0.5412
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
Mustang Bio Price to Book Value : 0.5435 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.5435 |
| September 04, 2026 | 0.5452 |
| September 03, 2026 | 0.5624 |
| September 02, 2026 | 0.5453 |
| September 01, 2026 | 0.5505 |
| August 31, 2026 | 0.5398 |
| August 28, 2026 | 0.5399 |
| August 27, 2026 | 0.5525 |
| August 26, 2026 | 0.5624 |
| August 25, 2026 | 0.5544 |
| August 24, 2026 | 0.5537 |
| August 21, 2026 | 0.5812 |
| August 20, 2026 | 0.5754 |
| August 19, 2026 | 0.5765 |
| August 18, 2026 | 0.5725 |
| August 17, 2026 | 0.5969 |
| August 14, 2026 | 0.5961 |
| August 13, 2026 | 0.5966 |
| August 12, 2026 | 0.608 |
| August 11, 2026 | 0.6106 |
| August 10, 2026 | 0.5926 |
| August 07, 2026 | 0.6033 |
| August 06, 2026 | 0.5777 |
| August 05, 2026 | 0.5995 |
| August 04, 2026 | 0.5966 |
| Date | Value |
|---|---|
| August 03, 2026 | 0.5791 |
| July 31, 2026 | 0.5727 |
| July 30, 2026 | 0.5964 |
| July 29, 2026 | 0.5825 |
| July 28, 2026 | 0.6341 |
| July 27, 2026 | 0.5624 |
| July 24, 2026 | 0.5644 |
| July 23, 2026 | 0.5726 |
| July 22, 2026 | 0.5935 |
| July 21, 2026 | 0.6184 |
| July 20, 2026 | 0.6548 |
| July 17, 2026 | 0.6309 |
| July 16, 2026 | 0.6473 |
| July 15, 2026 | 0.6347 |
| July 14, 2026 | 0.6653 |
| July 13, 2026 | 0.6667 |
| July 10, 2026 | 0.7066 |
| July 09, 2026 | 0.7431 |
| July 08, 2026 | 0.6827 |
| July 07, 2026 | 0.7129 |
| July 06, 2026 | 0.7129 |
| July 02, 2026 | 0.706 |
| July 01, 2026 | 0.7043 |
| June 30, 2026 | 0.705 |
| June 29, 2026 | 0.6167 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.658 |
| Alnylam Pharmaceuticals, Inc. | 25.10 |
| Anika Therapeutics, Inc. | 2.045 |
| Savara, Inc. | 7.735 |
| Vericel Corp. | 5.365 |
Price to Book Value Related Metrics
| Price | 0.5412 |
| Earnings Yield | -83.11% |
| Market Cap | 4.101M |